Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study.

MLA

Kulesza, Steven, et al. “Hydrocortisone versus Vasopressin for the Management of Adult Patients with Septic Shock Refractory to Norepinephrine: A Multicenter Retrospective Study.” Pharmacotherapy, vol. 43, no. 8, Aug. 2023, pp. 787–94. EBSCOhost, https://doi.org/10.1002/phar.2811.

APA

Kulesza, S., Gignac, L., Colvin, C. A., Boll, S., Giuliano, C., Haan, B., Allen, B., Perez, M. M., Allen, M., & Edwin, S. B. (2023). Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study. Pharmacotherapy, 43(8), 787–794. https://doi.org/10.1002/phar.2811

Chicago

Kulesza, Steven, Lindsey Gignac, C. Allis Colvin, Skyler Boll, Christopher Giuliano, Bradley Haan, Bryan Allen, Mary M. Perez, Monica Allen, and Stephanie B. Edwin. 2023. “Hydrocortisone versus Vasopressin for the Management of Adult Patients with Septic Shock Refractory to Norepinephrine: A Multicenter Retrospective Study.” Pharmacotherapy 43 (8): 787–94. doi:10.1002/phar.2811.